Tag Archives: DKD

Watch our CEO Robert Thong talk about how we are advancing precision medicine for metabolic-syndrome-related conditions at the LSX Investival Showcase in London.

Read more

MultiOmic Health, a leading AI-enabled drug discovery company, announces the identification of novel patient endotypes and the development of proprietary biomarkers for stratifying diabetic kidney disease (DKD) patients.

Read more

2/2